Hypertensive Crises

  • J. Varon
  • P. E. Marik
  • R. E. FrommJr.


Hypertension is a common clinical problem. Physicians across the world of multiple specialties are likely to encounter patients with hypertensive urgencies and emergencies. Various terms have been applied to these conditions; all characterized by acute elevations in blood pressure [1]. Prompt, but careful consideration of therapy is necessary to limit morbidity and mortality. Unfortunately, accelerated hypertension is amongst the most misunderstood and mismanaged of ‘acute’ medical problems seen in critical care medicine. Many healthcare providers concentrate on rapidly reducing an elevated blood pressure without understanding the pathophysiological principles involved and potential consequences.


Blood Pressure Aortic Dissection Elevated Blood Pressure Sodium Nitroprusside Severe Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Calhoun DA, Oparil S (1990) Treatment of hypertensive crisis. N Engl J Med 323: 1177 1183Google Scholar
  2. 2.
    Anonymous (1997) The sixth report of the Joint National Committee of Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157: 2413–2446CrossRefGoogle Scholar
  3. 3.
    Rey E, LeLorier J, Burgess E, Lange IR, Leduc L (1997) Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 157: 1245–1254Google Scholar
  4. 4.
    Prys-Rroberts C (1984) Anaesthesia and hypertension. Br J Anaesth 56: 711–724PubMedCrossRefGoogle Scholar
  5. 5.
    Strandgaard S, Olesen J, Skinhoj E, Lassen NA (1973) Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1: 507–510PubMedCrossRefGoogle Scholar
  6. 6.
    Haft JI, Litterer WE (1984) Chewing nifedipine to rapidly treat hypertension. Arch Intern Med 144: 2357–2359PubMedCrossRefGoogle Scholar
  7. 7.
    van Harten J, Burggraaf K, Danhof M, van Brummelen P, Breimer DD (1987) Negligible sublingual absorption of nifedipine. Lancet 2: 1363–1365PubMedCrossRefGoogle Scholar
  8. 8.
    Strauss R, Gavras I, Vlahakos D, Gavras H (1986) Enalaprilat in hypertensive emergencies. J Clin Pharmacol 26: 39–43PubMedCrossRefGoogle Scholar
  9. 9.
    Komsuoglu SS, Komsuoglu B, Ozmenoglu M, Ozcan C, Gurhan H (1992) Oral nifedipine in the treatment of hypertensive crises in patients with hypertensive encephalopathy. Int J Cardiol 34: 277–282PubMedCrossRefGoogle Scholar
  10. 10.
    Balser JR, Martinez EA, Winters BD, et al (1998) Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology 89: 1052–1059PubMedCrossRefGoogle Scholar
  11. 11.
    Platia EV, Michelson EL, Porterfield JK, Das G (1989) Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 63: 925–929PubMedCrossRefGoogle Scholar
  12. 12.
    Mooss AN, Hilleman DE, Mohiuddin SM, Hunter CB (1994) Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to ß-blocker therapy. Ann Pharmacother 28: 701–703PubMedGoogle Scholar
  13. 13.
    Tiberi M, Caron MG (1994) High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem 269: 27925–27931PubMedGoogle Scholar
  14. 14.
    Panacek EA, Bednarczyk EM, Dunbar LM, Foulke GE, Holcslaw TL (1995) Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group. Acad Emerg Med 2: 959–965Google Scholar
  15. 15.
    Shusterman NH, Elliott WJ, White WB (1993) Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am Heart J 95: 161–168Google Scholar
  16. 16.
    Elliott WJ, Weber RR, Nelson KS, et al (1990) Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation 81: 970–977PubMedCrossRefGoogle Scholar
  17. 17.
    White WB, Halley SE (1989) Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension. Arch Intern Med 149: 870–874PubMedCrossRefGoogle Scholar
  18. 18.
    Reisin E, Huth MM, Nguyen BP, Weed SG, Gonzalez FM (1990) Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension. Hypertension 15: I59–I62PubMedCrossRefGoogle Scholar
  19. 19.
    Pearce CJ, Wallin JD (1994) Labetalol and other agents that block both a-and ß-adrenergic receptors. Cleve Clin J Med 61: 59–69PubMedGoogle Scholar
  20. 20.
    Clifton GG, Cook ME, Bienvenu GS, Wallin JD (1989) Intravenous nicardipine in severe systemic hypertension. Am J Cardiol 64: 16H - 18HPubMedCrossRefGoogle Scholar
  21. 21.
    Clifton GG, Wallin JD (1990) Intravenous nicardipine: an effective new agent for the treatment of severe hypertension. Angiology 41: 1005–1009PubMedGoogle Scholar
  22. 22.
    Halpern NA, Sladen RN, Goldberg JS, et al (1990) Nicardipine infusion for postoperative hypertension after surgery of the head and neck. Crit Care Med 18: 950–955PubMedCrossRefGoogle Scholar
  23. 23.
    Schillinger D (1987) Nifedipine in hypertensive emergencies: A prospective study. J Emerg Med 5: 463–473PubMedCrossRefGoogle Scholar
  24. 24.
    Huysmans FT, Sluiter HE, Thien TA, Koene RA (1983) Acute treatment of hypertensive crisis with nifedipine. Br J Clin Pharmacol 16: 725–727PubMedCrossRefGoogle Scholar
  25. 25.
    Mann T, Cohn PF, Holman LB, Green LH, Markis JE, Phillips DA (1978) Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin. Circulation 57: 732–738PubMedCrossRefGoogle Scholar
  26. 26.
    Cohn JN, Franciosa JA, Francis GS, et al (1982) Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. N Engl J Med 306: 11291135Google Scholar
  27. 27.
    Robin ED, McCauley R (1992) Nitroprusside-related cyanide poisoning. Time (long past due) for urgent, effective interventions. Chest 102: 1842–1845Google Scholar
  28. 28.
    Vesey CJ, Cole PV, Simpson PJ (1976) Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man. Br J Anaesth 48: 651–659PubMedCrossRefGoogle Scholar
  29. 29.
    Pasch T, Schulz V, Hoppenshauser G (1983) Nitroprusside-induced formation of cyanide and its detoxication with thiosulphate during deliberate hypotension. J Cardiovasc Pharmacol 5: 77–85PubMedCrossRefGoogle Scholar
  30. 30.
    Hall VA, Guest JM (1992) Sodium nitroprusside-induced cyanide intoxication and prevention with sodium thiosuiphate prophylaxis. Am J Crit Care 2: 19–27Google Scholar
  31. 31.
    Wallace JD, Levy LL (1981) Blood pressure after stroke. JAMA 246: 2177–2180PubMedCrossRefGoogle Scholar
  32. 32.
    Lavin P (1986) Management of hypertension in patients with acute stroke. Arch Intern Med 146: 66–68PubMedCrossRefGoogle Scholar
  33. 33.
    O’Connell J, Gray C (1994) Treating hypertension after stroke. Br Med J 308: 1523–1524CrossRefGoogle Scholar
  34. 34.
    Prisant LM, Carr AA, Hawkins DW (1990) Treating hypertensive emergencies. Controlled reduction of blood pressure and protection of target organs. Postgrad Med 93: 92–96Google Scholar
  35. 35.
    Emergency Cardiac Care Committee and Subcommittees, American Heart Association (1992) Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Part IV, special resuscitation situations: stroke. JAMA 268: 2242–2244CrossRefGoogle Scholar
  36. 36.
    Adams HP, Brott TG, Crowell RM, et al (1994) Guidelines for the management of patients with acute ischemic stroke. A statement for the healthcare professionals from a special writing group of the stroke council, American Heart Association. Circulation 90: 1588–1601Google Scholar
  37. 37.
    Hirschl MM (1995) Guidelines for the drug treatment of hypertensive crises. Drugs 50: 991–1000PubMedCrossRefGoogle Scholar
  38. 38.
    Qureshi AI, Bliwise DL, Bliwise NG, Akbar MS, Uzen G, Frankel MR (1999) Rate of 23–hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: A retrospective analysis with a random effects regression model. Crit Care Med 27: 480–485Google Scholar
  39. 39.
    Lange RA, Cigarroa RG, Flores ED, et al (1990) Potentiation of cocaine-induced coronary vasoconstriction by ß-adrenergic blockade. Ann Intern Med 112: 897–903PubMedCrossRefGoogle Scholar
  40. 40.
    Pitts WR, Lange RA, Cigarroa JE, Hillis LD (1997) Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management. Prog Cardiovasc Dis 40: 6576CrossRefGoogle Scholar
  41. 41.
    Gay GR, Loper KA (1988) The use of labetalol in the management of cocaine crisis. Ann Emerg Med 17: 282–283PubMedCrossRefGoogle Scholar
  42. 42.
    Catravas JD, Waters IW (1981) Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther 217: 350–356PubMedGoogle Scholar
  43. 43.
    Boehrer JD, Moliterno DJ, Willard JE, Hillis LD, Lange RA (1993) Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 94: 608–610PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • J. Varon
  • P. E. Marik
  • R. E. FrommJr.

There are no affiliations available

Personalised recommendations